Brief: Adial Pharmaceuticals Names Cary Claiborne As Chief Executive Officer
22/08/2022 21:31
Aug 22 (Reuters) - Adial Pharmaceuticals Inc ADIL.O :
* ADIAL PHARMACEUTICALS NAMES CARY CLAIBORNE AS CHIEF
EXECUTIVE
OFFICER
* ADIAL PHARMACEUTICALS INC - WILLIAM STILLEY MOVES TO POST
OF CEO
OF ADIAL'S SUBSIDIARY, PURNOVATE
* ADIAL PHARMACEUTICALS INC - KEVIN SCHUYLER APPOINTED
CHAIRMAN OF
ADIAL'S BOARD
Source text for Eikon: ID:nGNX3H71pB
Further company coverage: ADIL.O
Recent news on Adial Pharmaceuticals
See all newsBrief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)